Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04025398

A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability

REHABILITUS: a New Cognitive Remediation Tool for Adults With Intellectual Deficiency With Behavioral Disorders

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Hôpital le Vinatier · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Adults with intellectual disabilities have great difficulty in adapting to social situations and relationships. Cognitive impairment associated with intellectual disability are important factors to understand their difficulties in processing social information. In the field of recognition of facial emotions in particular, basic cognitive processes such as visuospatial and attentional functions, are heavily involved. Cognitive remediation is a management tool widely used by practitioners to help patients who experience cognitive difficulties. Currently, no program can meet specific and validated the problems are adults with intellectual disabilities manner in their daily functioning

Detailed description

Réhabilitus is a remediation program focused on attentional functions and visuospatial, to limit the presence of behavioral disorders among adults with intellectual disabilities. The main objective is to validate the effectiveness of Réhabilitus program on behavioral disorders in adults with intellectual disabilities without autism spectrum disorder associated.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive remediation programComparison between a cognitive remediation program (REHABILITUS) (group 1) and a training group of manual activities (group 2)
BEHAVIORALControl groupComparison between a cognitive remediation program ("Réhabilitus") (group 1) and a training group of manual activities (group 2)

Timeline

Start date
2020-06-17
Primary completion
2026-06-17
Completion
2026-12-31
First posted
2019-07-18
Last updated
2025-07-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04025398. Inclusion in this directory is not an endorsement.